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 Pressure ulcers (PrU) are a leading secondary medical complication in the spinal cord injury 
(SCI) population. With over two hundred known risk factors, PrU prevention is extremely 
complex but can provide an astounding difference in a patient’s recovery. Multiple risk 
assessment scales allow us to quantify risk across a broad range of populations, yet the literature 
provides little evidence that these tools are representative of PrU development in the SCI 
population. The Pressure Ulcer Assessment Scale for the Spinal Cord Injured (Salzberg Scale) is 
a risk assessment scale specific to the SCI population, composed of fifteen risk factors that 
divide PrU development risk into four categories. The objective of this thesis is to assess the 
predictive validity of the Salzberg Scale during acute care and inpatient rehabilitation following 
spinal cord injury.   
Data was extracted from a primary study on PrU outcomes for newly injured traumatic 
SCI patients in acute care and inpatient rehabilitation. A secondary analysis assigned subjects a 
raw Salzberg Scale score based on collected medical information and Salzberg Scale component 
definitions. The Salzberg scores were used to compute sensitivities, specificities, and accuracy of 
the scale with newly defined risk cut-off scores for acute hospitalization and inpatient 
rehabilitation.  
Sensitivity and specificity were calculated for the scale’s ability to predict PrU ranging 
from two to 22 days after administration of the Salzberg Scale risk assessment tool. The use of 
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the scale in the acute care hospitalization to assess risk for PrU within 2-3 days showed the only 
strong predictive results with an area under the curve (AUC) of 0.8482 at the indicated cutoff 
score of 15. The sensitivity of 100.0% and a specificity of 75.0%, showed a more accurate 
prediction balance than the validation study conducted by Salzberg on a broader population 
sample. Overall, failure of the scale’s predictive ability to predict a pressure ulcer over a longer 
time period suggests further studies must be completed in order for the scale be recommended 
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1.0  INTRODUCTION 
1.1 DISCUSSION OF PROBLEM 
Pressure ulcers (PrU) are a leading secondary medical complication in the spinal cord injury 
(SCI) population.51, 65 Pressure ulcer development has been known to interfere with the physical, 
psychological, and social aspects of well-being along with impacting overall quality of life.48 
With over 200 known risk factors and treatment costing about $1.3 billion annually, pressure 
ulcer prevention is extremely complex but can provide an astounding difference in a patient’s 
recovery and save money for the patient and hospital system.19  
More than thirty-eight scales allow us to quantify risk across a broad range of 
populations, yet the literature provides little evidence that these tools are representative of 
pressure ulcer development in the SCI population.7, 19, 51 Unlike the most popular and well 
researched scales such as the Braden Scale, the Norton Scale and the Waterlow Scale, the 
Pressure Ulcer Assessment Scale for Spinal Cord Injured (referred to as Salzberg Scale or 
SCIPUS) is a risk assessment scale created specifically to identify risk of pressure ulcer 
development in the SCI population.  
Proper identification of individuals with SCI at risk for PrU development and initiation of 
appropriate preventative practices is necessary to lower the PrU incidence and prevalence.7 
Evaluation of risk assessment scales and other general prevention measures have been flagged as 
crucial by various health reviews in the United States. Healthy People 2010 lists reduction of 
pressure ulcer incidence as an a main objective for healthcare providers.71 In addition, more 
research on preventative tools is urgent in accordance to the Deficit Reduction Act of 2005. As 
of 2008, hospitals are no longer to receive compensation or reimbursement for “care related 
conditions” such as pressure ulcers that occur during “incident hospitalization” as they were 
deemed a preventable condition.32 
Overall, if risk assessment and prevention are not incorporated in healthcare practice, 
pressure ulcer development will continue to be a burden on the lives of those with SCI in various 
physical, psychological, as well as economical ways. Defining the risk cut off scores of the 
Salzberg Scale is essential in order to properly assess the already high-risk SCI population. 
Limited use of the Pressure Ulcer Assessment Scale for the Spinal Cord Injured suggests positive 
findings for the general SCI population, yet the tool has not been analyzed for the acute 
hospitalization and inpatient rehabilitation of new, traumatic SCI individuals. The objective is to 
evaluate the psychometric properties of the Salzberg scale in order to provide evidence 
predictive validity in new, traumatic SCI individuals.  
1.2 OBJECTIVES AND SPECIFIC AIMS 
 
The objective of this thesis was to assess the predictive validity of the Salzberg Scale during 
acute care and inpatient rehabilitation following spinal cord injury.   
This retrospective secondary analysis covered three main aims. Each aim was 
accomplished using the Rehabilitation Engineering Research Center (RERC) on Spinal Cord 
 ii 
Injury clinical data collected on new, traumatic spinal cord injury subjects from acute care and 
inpatient rehabilitation settings. Collected from 2008 through 2012, the data set included detailed 
objective clinical tests including diagnoses and medical comorbidities, pain and depression 
scores, ambulatory and medication descriptions, as well as Braden Scale scores for each subject 
assessment date. Through data outcome compilation, raw Salzberg Scale scores were calculated 
and used for analysis of psychometric properties of the scale.  
The initial aim verified the generalized statement that the Salzberg Scale predicts 
pressure ulcer formation in the SCI population. The descriptive analysis assessed the difference 
in scores between those with and without pressure ulcer formation. The second aim evaluated 
risk cut-off points within the RERC study population. New sensitivities and specificities were 
calculated in order to define potential “Risk Cut-Off Point” associated with new, traumatic SCI. 
Each population will have its own specific risk scores associated with specific characteristics of 
its population demographics and injury severity. This is the basis of newly calculated risk cut-off 
point establishment. Thirdly, the new sensitivities and specificities were used to evaluate the 
accuracy and power of the Salzberg Scale scoring using an ROC Curve.  
1.3 ORGANIZATION OF THE THESIS 
 
Six chapters follow the introduction. Chapter 2 is a review of the literature on pressure ulcer 
research focusing on risk factors for the development of pressure ulcers in the SCI and other 
populations.  Chapter 3 is a review of PrU prevention techniques, specifically the use of 
validated risk assessment. Chapter 4 contains a description of the research design and methods 
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used in this study. Chapter 5 provides the results. Chapter 6 is a discussion of the results. Lastly, 
Chapter 7 summarizes the work, explains limitations, and gives future directions of the research.  
 iv 
2.0  REVIEW OF THE LITERATURE 
2.1 PRESSURE ULCER DEVELOPMENT IN INDIVIDUALS WITH SPINAL CORD 
INJURY (SCI) 
2.1.1 Definition 
For this study, the definition of a pressure ulcer is defined by the National Pressure Ulcer 
Advisory Panel. Based on the 2012 revision, pressure ulceration is defined by the following: “A 
pressure ulcer is a localized injury to the skin and/or underlying tissue usually over a bony 
prominence, as a result of pressure, or pressure in combination with shear. A number of 
contributing or confounding factors are also associated with pressure ulcers; the significance of 
these factors is yet to be elucidated.”56 The majority of pressure ulcers are found below the waist, 
specifically the skin overlying the bony prominences such as sacrum, trochanters, ischium, and 
heels, but can be found anywhere on the body where pressure and compressive forces are 
maintained for a sufficient period of time.9, 49, 76 PrU are also known as decubitus ulcers, pressure 
sores, and/or bed sores. 9 
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2.1.2 Clinical Diagnosis and Staging 
Staging of PrUs is completed after the clinical diagnosis and identification of PrU development. 
This can be completed though visual inspection and/or palpation.37 Various systems have been 
developed for the classification of pressure ulcers. Consistently recognized by the Wound 
Ostomy and Continence Nurses Society (WOCN), the National Pressure Ulcer Advisory Panel 
(NPUAP) staging system is a favored set of guideline for pressure ulceration diagnosis. 2, 22 
Created in 1989, the original NPUAP staging system was composed of a four-stage system 
similar to the earliest systems created by Guttmann in 1955.13 Based on the growing popularity 
of the NPUAP Staging System, the European Pressure Ulcer Advisory Panel (EPUAP) also 
developed a similar system in 1998. The EPUAP Staging System was not adopted for diagnostic 
use in the United States since inter-observer reliability was low and there is still a need for clarity 
within the staging definitions.1, 11  
Following the creation of the NPUAP Staging System, factors such as accuracy, 
consistency, and inter-rater reliability of the staging system were investigated. Of the four stages, 
nurses exhibited uncertainty differentiating between Stage II and Stage III pressure ulcers.  
Diagnostic inaccuracies led to the reevaluation of the NPUAP Staging System.13 At the 2005 
Consensus Conference, NPUAP acknowledged the idea that suspected deep tissue injury (sDTI) 
as well as unstageable categories were etiologies of pressure ulcer formation yet they could not 
be accurately described by the existing staging system.14 Through solicitation of current facilities 
using NPUAP guidelines, the NPUAP presented a newly drafted scale for participants to 
comment on “the qualities of clarity, succinctness, accuracy, and discrimination for each 
definition.”13 Refinement of the updated staging system was solidified at the 2007 NPUAP 
Consensus Conference.29 The most recent revision (2012) was adopted and is currently used 
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today. The current NPUAP staging definitions are represented in Table 1.56  Today, the NPUAP 
and EPUAP have a unified recommendation and definition system that is referenced often.35 
Table 1. 2012 NPUAP Staging System 
Stage 2012 NPUAP Staging System Definitions 
1 
          Intact skin with non-blanchable redness of a localized area usually 
over a bony prominence. Darkly pigmented skin may not have visible 
blanching; its color may differ from the surrounding area. The area may be 
painful, firm, soft, warmer or cooler as compared to adjacent tissue. 
Category I may be difficult to detect in individuals with dark skin tones. 
May indicated “at risk persons” (a heralding sign of risk) 
2 
          Partial thickness loss of dermis presenting as a shallow open ulcer 
with a red pink wound bed, without slough. May also present as an intact or 
open/ruptured serum-filled filled blister. Presents as a shiny or dry shallow 
ulcer without slough or bruising.* This stage should not be used to describe 
skin tears, tape burns, incontinence associated with dermatitis, maceration 
or excoriation.  
         *Bruising indicates deep tissue injury.  
3 
          Full thickness tissue loss. Subcutaneous fat may be visible but bone, 
tendon or muscles are not exposed. Slough may be present but does not 
obscure the depth of tissue loss exposed. Slough may be present but does 
not obscure the depth of tissue loss. May include undermining and 
tunneling. The depth of a Category/Stage III pressure ulcer varies by 
anatomical location.  
4 
          Full thickness tissue loss with exposed bone, tendon, or muscle. 
Slough or eschar may be present. Often includes undermining and 
tunneling. The depth of a Category/Stage IV pressure ulcer varies by 




          Purple or maroon localized are of discolored intact skin or blood-
filled blister due to damage of underlying soft tissue from pressure and/or 
shear. The area may be preceded by tissue that is painful, firm, mushy, 
boggy, warmer or cooler as compared to adjacent tissue. Deep tissue injury 
may be difficult to detect in individuals with dark skin tones.  
Unstageable 
          Full thickness tissue loss in which the based of the ulcer is covered by 
slough (yellow, tan, gray, green, or brown) and/or eschar (tan, brown, or 
black) in the wound bed. Until enough slough and/or eschar are removed to 
expose the base of the wound, the true depth cannot be determined; but it 
will be either a Category/Stage III or IV.  
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2.1.3 Etiology 
Though the exact etiology of pressure ulceration is not fully understood, researchers have 
hypothesized pressure ulcer origins through four pathophysiological pathways.75  The first of the 
hypotheses is based on localized ischemia caused by capillary occlusion reasoned by pressure 
loading.23, 27 Ischemia, the insufficient supply of blood to an organ, prevents oxygen, essential 
nutrients and metabolites from being carried to and away from cells. This, in turn, causes the 
buildup of various cell waste products leading to the degradation and death of localized cells.53,60 
Another explanation refers to reperfusion injury theory. Reperfusion injury is an injury that 
results from the accumulation of inflammatory substances in the body as blood is reintroduced to 
an area previously affected by ischemia.38 The third hypothesis of pressure ulcer encompasses 
the impaired lymphatic function in the body which causes accumulation of metabolic waste 
products and enzymes exhibiting similar responses as ischemia in a previous hypothesis.50  
Shear force may increase of PrU development.43 Shear forces are parallel to the skin 
surface. It has the ability to damage blood vessels and compromise the blood supply leading to 
ischemia, necrosis, and cellular death.49, 53 An example of shear force occurs when a person is in 
a hospital bed. When the back of the mattress is elevated, the weight of the upper body slides 
downward toward the bottom of the hospital bed. There is an opposing, parallel force that causes 
deformation. Though previously suggested that the frictional force may lead to the development 
of PrU, the 2009 International NPUAP-EPUAP Pressure Ulcer Prevention and Treatment 
Clinical Practice Guideline eliminated the frictional force as a factor. Despite friction resisting 
the shearing force, friction relates mainly to skin injuries that are not considered to be a PrU. 
Friction that causes shear strain in the tissue potentially leads to the increase in tissue breakdown, 
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which leads to PrU development. The sole force of friction cannot allow an injury to be 
categorized as a PrU.6  
 Overall, there are two popular theories describing the mechanisms of pressure ulcer 
development and progression. The first theory states that pressure ulcers form deep within the 
muscle tissue, close to the bone, and move outward toward the superficial layers of the skin. This 
is known as the deep tissue injury theory.40 Deep tissue injury arises when the muscle layers 
adjacent to the bone endure sustained loading. They are not necessarily visible until the 
unrelieved, ischemic injury and local necrosis reach the outer layers of the skin.49, 53, 61, 73 The 
second, and lesser popular model, is the top to bottom model. This model states that pressure 
ulcer formation begins from the superficial skin destruction at the dermis through forces such as 
friction, and the injury proceeds inward toward the deeper tissue.15, 61  
2.1.4 Risk Factors 
Due to the drastically altered physiology of a SCI patient immediately after injury, pressure ulcer 
formation is a leading health care problem.41 Major factors associated with pressure ulcer 
development are level of activity, ambulation and level of mobility, incontinence, as well as 
severity of injury.7, 10, 66 There are over 200 noted risk factors for pressure ulcer development in 
the SCI population.19 The fifteen risk factors chosen by Salzberg will be discussed thoroughly in 
the third chapter of this thesis. These factors include level of activity, level of mobility, 
completeness of SCI, urinary incontinence or moisture, level of spasticity, age (years), tobacco 
usage, past or current pulmonary disease, past or current cardiac disease, glucose levels, past or 
current renal disease, impaired cognitive function, health care setting of pressure ulcer 
development, current albumin levels, and current hematocrit levels.67 Each of these fifteen risk 
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factors designated in the Pressure Ulcer Risk Assessment Scale for the Spinal Cord Injured will 
be discussed in detail on later pages.  
2.1.5 Incidence and Prevalence 
PrU incidence and prevalence varies by population and healthcare setting. In 2005 Chen et al 
conducted a study noted in the review using secondary complication data from the National 
Spinal Cord Injury Database. Chen et al. identified that the risk of developing a PrU was 
consistent over the first ten years post-injury (prevalence rate of 11.5% to 14.3% for Stage II or 
higher PrU) while risk eventually increased 15 years post injury (prevalence rate of 21.0% Stage 
II or higher PrU).20 Pagliaccci et al found that 26.9% of 684 people with newly, traumatic SCI 
admitted to one of 32 rehabilitation centers in Italy presented with one or more PrU as well.54 It 
has been recommended that the development of innovative strategies for prevention of PrU is 
needed to lower the high incidence and prevalence of PrU.22 
 Incidence and prevalence of pressure ulcer development has been difficult to collect 
based on various pressure ulcer classification systems, inconsistent data collection and 
identification from multiple sources, as well as studies evaluating prospectively versus 
retrospectively.31 According to data collected from the Model Spinal Cord Injury Systems 
(MSCIS) one third of individuals with SCI will develop at least one PrU in their initial acute or 
inpatient rehabilitation care. Thereafter, between 15%-33% of persons with SCI will develop 
pressure ulcers once in community settings.41 With a range of 232,000 to 316,000 individuals 
with SCI in the United States, up to 85% will develop a pressure ulcer at some point during their 
life.47, 62, 72 In addition, PrU-related complications cause up to 60,000 deaths a year, 7%-8% of 
these involving those with persons with SCI. 44  
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2.1.6 Financial Impact 
Though costs of treating pressure ulcers vary based on severity of the ulcer, each year, the United 
States spends more than $1.3 billion annually on treatment costs.19, 43, 65 The highest estimation is 
upwards of $5 billion for treatment and management of pressure ulcers.44, 52 In 2011, the cost of 
healthcare and living expenses of SCI patients ranged from $1,461,255 in the case of a minor 
injury all the way to the exorbitant $4,373,912 in the case of high level tetraplegia (C1-C4).72 
Out of these estimated healthcare and living expenses, 25% are attributed to treatment of 
pressure ulcers.19  
Partial thickness pressure ulcers (Stage I or Stage II) are estimated to cost $125-$451 per 
incidence. For more severe pressure ulcers, full thickness pressure ulcers (Stage III and Stage IV 
and sDTI) cost an estimated $14,000-$25,000 per ulcer to treat.58, 80 The cost of the pressure 
ulcer is higher with a more severe stage based on longer healing times and increased likelihood 
for complications.46, 51 The magnitude of pressure ulcer development has been linked to 
increased hospital stays of approximately four days as well as prolonged nursing care time by 
nearly fifty percent.30, 80 As noted, pressure ulcer development comes at a “tremendous personal 
and societal cost.”45, 51 Implementation of preventative measures may decrease pressure ulcer 
incidence and in turn lower its financial impact.12, 25, 26, 34, 51  
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3.0  ASSESSMENT SCALES TO ASSESS PRESSURE ULCER RISK 
3.1 SCALES FOR GENERAL POPULATION 
3.1.1 The Braden Scale, Norton Scale, and Waterlow 
Various risk assessment scales have been created in order to aid clinicians in the proper 
implementation of preventative measures for patients at risk for PrU development. Whether in a 
nursing home setting or a surgical unit, risk assessment scales have been made to be general or 
modified to a specific population at risk for developing PrU.16, 59 It has been concluded that 
informal risk assessment such as skin integrity examination of a patient cannot take the place of a 
formal risk assessment.7 Three of the most common PrU risk assessment scales are the Braden 
Scale, Norton Scale and the Waterlow Scale.  
The first risk assessment scale created to evaluate PrU development risk was the Norton 
Scale in 1962.70 Developed for the geriatric population, it is composed of five items: physical 
condition, mental state, activity, mobility, and incontinence. Each item is rated from 1 (very bad) 
to 4 (very good) with a maximum score of 20 points.57 Scrutinized for its validity, patients with a 
cutoff score of fifteen or sixteen points or higher are considered at risk for pressure ulcer 
development.30 Newer scales have been modeled off of the Norton Scale by redefining risk 
factors as described by recent research studies.26 
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The second scale created and modeled after the Norton scale is the Waterlow Scale. 
Known to be more accurate at predicting pressure ulcers in orthopedic patients as compared to 
Braden Scale and Norton, the Waterlow Scale consists of eight items: build/weight for height, 
visual assessment of the skin in the area at risk, sex and age, continence, mobility, appetite, 
medications, and special risk factors. Unique to the scale is its weighted risk factors that vary in 
score distribution depending on the risk indicator contribution to PrU development.30, 57 
Receiving a score of 16 or above, defined cutoff point for at-risk patients in clinical studies 
predicts PrU development. This means that patients are considered at higher risk when there is an 
increase in the sum of the eight categories. The scale has patient risk broken down into 
categories of at risk, high risk, and very high risk.3, 78 
The third and most popular scale is the Braden Scale. Created it 1987, it has been 
concluded to be the best risk assessment scale due to its extensive reliability and validity testing 
to date.55, 69 Composed of six subscales, the Braden Scale incorporates sensory perception, 
activity, mobility, moisture, nutrition, and friction/shear. Each subcategory is rated from 1 to 4 
points with friction/shear rated only from 1 to 3 points. Unlike other scales, a score lower than 
16-18 points subjects a patient to be at higher risk for PrU development. Since its introduction, 
various cut-off scores have been recommended based on the specific population of patients. 
Studies validating the use of this scale have had sensitivities ranging from 79% to 100% over a 
variety of treatment settings.43 The Braden scale has multiple strengths. Whether it be its high 
utility in clinical or research settings, existing validity and reliability evidence, or inclusion of the 
latest indicative factors of PrU risk, the Braden Scale has had consistent implementation since its 
creation.39 
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Between these three scales, it is very difficult to compare the predictive validity as many 
validation studies, characteristic research methods, and outcome measures are evaluated in each 
study.8 In some studies, the Waterlow and Braden are represented as having the best sensitivities 
whereas the Norton Scale has the best specificity. 8, 57 Contrasting these studies, there are articles 
which state that the Braden Scale results has superior predictive validity based on prospective 
versus retrospective studies. 24 Overall, all risk assessment instruments identified more patients at 
risk of PrU development over clinical judgment alone.8   
 
3.1.2 Validity for SCI Patients 
Though the Norton Scale, Waterlow Scale, and Braden Scale have been validated for use in 
hospital settings and nursing homes, they lack application and validation of specific populations 
such as the SCI population.51 The predictive value of existing risk assessment tools are imprecise 
for the SCI population as they were originally designed for the general medical population.33 WB 
Mortenson et al. completed a systematic review of risk assessment scales for pressure ulcer 
development using the SCI population.51  Of the seven scales incorporated into the review, the 
Norton Scale, Waterlow Scale, and Braden Scale were evaluated.  
Based on previous studies regarding reliability, validity, administrator burden and 
respondent burden, each of these three scales had poor to adequate predictive validities with the 
spinal cord injury population. Being that the spinal cord injury population is initially at high risk 
for PrU development, it is crucial that a risk assessment scale identify the specific risk of this 
population.36 As stated so precisely in an analysis describing usability of surveys on various 
population, “[G]eneralizability Theory indicates that [previous] results cannot be applied to 
 10 
individuals with SCI, which undermines confidence in these scales to reproduce stable results 
over time with this population.”21 This means that there were such a small subpopulation of SCI 
subjects included in the various studies assessing the three scales, that the overall predictive 
validity could not be attributed to the SCI subpopulation’s contribution.  
Lack of content validity causes institutions to assume the scale’s application to the 
population. Given that the Braden Scale and Waterlow performed similarly and closest to 
adequate scoring based on psychometric property evaluation, these scales are the best tools that 
are currently available despite benefitting from additional testing within the SCI population.51 
Included in the systematic review was the Salzberg Scale. This was the only scale made 
specifically for the risk assessment of the SCI population. Despite its higher sensitivity (74.7%) 
and specificity (56.6%) scores, it could not be deemed the best assessment tool since has not 
been validated. Mortenson et al. advised that the Salzberg Scale undergo further psychometric 
testing in order for recommendation. Lastly, more prospective studies that allow head-to-head 
comparison of these risk assessment scales would represent a stronger method to evaluate 
concurrent and construct validity for proper direct recommendation of a SCI specific risk 
assessment tool.28, 51  
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3.2 SCALE FOR SCI POPULATION 
3.2.1 Development of Scales 
With over 250,000 individuals with SCI in the United States, currently no method exists to 
accurately identify which of these individuals will have a higher risk for developing pressure 
ulcers.67  This idea sparked the curiosity of colleagues Dr. Andrew Salzberg and Daniel Byrne. 
Developing a research interest in the early 1990s, Salzberg and Byrne set out to perform a 
systematic review of literature regarding the many risk factors associated with pressure ulcer 
development for people with SCI. 19, 52, 65 the Norton Scale, the Gosnell Scale, and the Braden 
Scale were addressed specifically for their lack of content validity in the systematic review.19 In 
addition to these three scales, other papers have cited that the Waterlow Scale also lacked content 
and concurrent validity.55, 79 
Certain criticism pertaining to these scales revolve around their vaguely defined risk 
factors, lack of weighting of risk factor for emphasis, and better prediction based on medical 
practitioner intuition.64, 77 In addition, inadequate number of individuals with SCI in sample sizes 
and various confounding variables make justifying the results of formerly created scales to the 
SCI population difficult. The results of the systematic review led to a reduction of the 200 known 
risk factors to a succinct list of fifteen. These fifteen tailored risk factors to the SCI population 
were incorporated in the Pressure Ulcer Risk Assessment for the Spinal Cord Injured.  
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3.2.2 Pressure Ulcer Risk Assessment for the Spinal Cord Injured 
The first study on the Pressure Ulcer Risk Assessment for the Spinal Cord Injured, commonly 
referred to as the Salzberg Scale was published in 1996.67 Salzberg and Byrne et al included the 
previously established fifteen risk factors that correlate to pressure ulcer development in the SCI 
population. Stated in their original study, these fifteen factors were included based on four main 
criteria. The fifteen risk factors must have some form of statistical association with pressure 
ulcer development in the SCI population. In addition, each risk factor included in the scale had a 
plausible biological mechanism, literature support as well as relate to the improved prediction of 
pressure ulcer development.67 The fifteen risk factors included in the study were level of activity, 
degree of mobility, completeness of SCI, urinary incontinence, diagnosis of autonomic 
dysreflexia, age, comorbidities such as those pertaining to cardiac, pulmonary, and renal 
pathophysiology, level of cognition, diagnosis of diabetes, history of cigarette smoking, 
residency, and diagnosis of hypoalbuminemia and anemia. 
Each risk factor is weighted differently ranging from a value of 0, 1, 2, 3, or 4 points 
based on their significance and relevance to pressure ulcer development. Those with the largest 
score determination are level of activity, level of mobility, age, history of tobacco use, existing 
pulmonary disease, and location of residence. These all have a possibility of contributing two or 
more points to the total score at the time of assessment. To determine which score should have 
been assigned to the subject or patient, Salzberg provided an objective, easily defined list of 
operational definitions. Each category must be filled out to create a total score. Total scores 
range from 0 to 25 points. The lower the compiled score, the lower the level of risk a person will 
have for pressure ulcer development.  
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3.2.3 Risk Category Breakdown 
In the process of developing the Salzberg Scale, Salzberg and colleagues established four 
categories to define the amount of risk. The four categories can be seen in Table 2 below. 
Table 2 Salzberg Scale Risk Categories 




VERY HIGH 9-25 
 
These categories were based on initial sensitivity and specificity analysis of 219 subjects. Their 
data indicated that patients with a score greater than 6 had the ‘highest balance of sensitivity and 
specificity, demonstrated by the intersection of the sensitivity and specificity lines.’67 As 
recommended by Salzberg, Braden, as well as W.B. Mortenson, each specific setting should test 
baseline risk categories on the population they study or treat. This way, the scale is personalized 
and specific for the appropriate settings use. It is essential that the tool be tested on the intended 
population prior to implementation.  
3.2.4 Previous Use of Scale 
The Salzberg Scale has been used in a limited amount of studies.34, 51, 67, 68 Its usage varies from 
its preliminary psychometric testing to additional medical record support in larger interventional 
studies.10 Use of this scale is found in trace studies due to its lack of validity and popularity as a 
promising measurement tool. In 2007, W.B. Mortenson et al. composed a systematic review of 
risk assessment scales for pressure ulcer development in individuals with SCI.51 Information on 
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the Salzberg Scale as well as six other risk assessment scales was evaluated based on published 
results of each scales reliability, validity, respondent burden, and administrative burden. Of all 
tools, the Salzberg Scale had the most items to assess with its unique categories of autonomic 
dysreflexia and living setting. It was identified that the Salzberg Scale had the best sensitivity 
and specificity of all measures tested during acute care hospitalization as well. It also had the 
highest construct validity. What diminishes the scale’s high sensitivity and construct validity is 
its only application in retrospective studies and limited published results.51  
Despite the Salzberg Scale being customized for the assessment of individuals with SCI, 
there is still the criticism of minimal reliability data and general population use in other studies 
than its founding study. It has yet to be recommended until further psychometric evaluation is 
completed.33 Additionally, the predictive value of the Salzberg Scale in various settings (e.g., 
community or hospital) requires investigation as well.  
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4.0  RESEARCH DESIGN AND METHODS 
Data collection was made possible by the Rehabilitation Engineering Research Center on Spinal 
Cord Injury (RERC-SCI). The RERC-SCI assists persons with SCI through research and 
development of technologies that can be incorporated into the improvement of rehabilitation and 
reintegration of persons into society. Made up of developmental and research projects, the 
clinical core of this particular study was designed to enroll new, traumatic SCI patients for the 
collection of demographic information, medical information, pressure ulcer outcomes, and urine 
and blood samples during the acute, inpatient, and outpatient stages of rehabilitation. For a 
complete listing of variables collected, see Table 3.    
Informed consent reviewed and approved by the University of Pittsburgh Institutional 
Review Board (IRB) was obtained for both the RERC-SCI study and amended for the 
retrospective secondary analysis. Patients enrolled were charted at the University of Pittsburgh 
Medical Center (UPMC) facilities and after discharge. The Clinical Core of RERC-SCI 
collaborated with UPMC and the UPMC Model System on SCI to recruit, screen, and enroll 
subjects with new, traumatic SCI. All personnel in the Clinical Core team were qualified to 
collect data and perform proposed responsibilities.  Data was taken from each enrolled patient 
three times a week during acute care hospitalization, once a week during inpatient rehabilitation, 
and annually after discharge in outpatient care. Outpatient follow-up consisted of six months, 
twelve months, and yearly time points until the conclusion of the study. All evaluations 
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continued thru the termination of the study. The RERC-SCI was funded by the National Institute 
on Disability Rehabilitation Research grant, #H133E070024.  
 
Table 3. Data Collected for RERC-SCI 
Variables Categories Variable Specifics 
Demographics Admission Date, Consent Date, Date of Injury, Age, Sex, Marital Status, 
Ethnicity, Height, Weight, Past Medical History (PMH) of Smoking 
Injury Cause of Injury; Level of Injury: Cervical, thoracic, Lumbar, Sacral, 
Coccyx, Other; Bilateral vs. left and right; Complete vs. Incomplete; 
American Spinal Injury Classification (ASIA) score, Lower Extremity 
Score Injury Severity Score (ISS) 
Medical Information Alcohol Use, Tobacco Use, Musculoskeletal Pain, PHQ Depression 
Scale, Medical Comorbidities (cardiovascular, hematopoietic, 
respiratory, ENT, gastrointestinal, rheumatologic, musculoskeletal, 
neurologic, endometric/metabolic, immunological, psychiatric, 
malignancy, substance abuse, UTI, integumentary), Number of Pressure 
Ulcers, Braden Risk Score, Bladder and Bowel Management, 
Medications (NSAIDs, Steroids, Antibiotics, and Others), Ambulation 
Status  
Pressure Ulcer Size, Shape, Severity (based on NPUAP Staging System), Progression 
of the PU 
 
4.1 RESEARCH DESIGN 
This study was a retrospective secondary analysis of the data collected by the clinical core of 
RERC-SCI. Using the existing database information, specific variables pertaining to the Salzberg 
Scale were extracted to evaluate the psychometric properties of the scale. The extracted variables 
were the fifteen risk factors that composed the Salzberg Scale, demographic information of 
included subjects, and assessment dates for time point analysis in both acute care hospitalization 
and inpatient rehabilitation. The extracted variables were recorded at each subject assessment 
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The extracted data were then put into a separate database for lucid analysis of the particular 
psychometric properties of the scale. The psychometric properties evaluated were sensitivity, 
specificity, Receiver Operating Curve (ROC) Curve, and other predictive validity measures. 
These properties are explained in further detail in 4.4 DATA ANALYSES. Table 4 conveys the 
extracted variables used to organize the secondary analysis data.  
 
Table 4. Secondary Analysis Data Extracted 
Secondary Analysis 
Variables Categories Secondary Analysis Variable Specifics 
Demographics Admission Date, Consent Date, Date of Injury, Age, Sex, Marital 
Status, Ethnicity, Height, Weight, Past Medical History (PMH) of 
Smoking, Rehabilitation Stage, Assessment Date, Current 
Residence 
Injury Complete vs. Incomplete; American Spinal Injury Classification 
(ASIA) score, 
Medical Information Tobacco Use, Medical Comorbidities (cardiovascular, 
hematopoietic, respiratory, gastrointestinal, neurologic, 
immunological, psychiatric, integumentary), Number of Pressure 
Ulcers, Ambulation Status, Albumin Levels, Hematocrit Levels, 
Bladder and Bowl Management 
Pressure Ulcer Incidence Date 
4.2 SUBJECT INCLUSION AND EXCLUSION CRITERIA 
4.2.1 Primary Study Subject Inclusion and Exclusion Criteria 
In the primary RERC on SCI study, subjects with new, traumatic SCI were recruited within 24-
72 hours after admission to UPMC Neurotrauma Centers. Subjects were eligible to be in the 
study if they met the following criteria: 
1) Received acute medical and/or surgical treatment at UPMC hospitals 
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2) Received acute rehabilitation at Institution of Rehabilitation Research (IRR) 
South Side or UPMC Mercy after the acute medical and/or surgical treatment 
3) Are 18 years and older 
4) New, acute traumatic SCI (e.g. motor vehicle accident, fall, sports injury, gunshot 
wound) 
Subjects were to be automatically excluded from the study if they had any of the following: 
1) Pre-existing diseases that would affect the inflammatory response to SCI (e.g. 
autoimmune or demyelinating diseases) 
2) Previous SCI or other neurological dieses that affect the motor or sensory function 
of the subject  
In the RERC on SCI study, 104 subjects were enrolled from 2008 through 2012. At the 
end of the study, 48 subjects were still enrolled in the study, 13 subjects were out of the study 
due to death or lost to follow-up, and the remaining 43 subjects withdrew themselves from the 
study for reasons such as lack of interest or dislike of blood draws.  
4.2.2 Secondary Study Subject Inclusion and Exclusion Criteria 
For the current analysis, 51 subjects of the original 104 subjects were included for this study. 
Subjects were eligible to participate in the current study if they met the following criteria: 
1) Did not voluntarily withdraw from RERC-SCI study  
2) Contain all information required for the Salzberg Scale component extraction and 
other analysis data (e.g., Braden Scale, ASIA score, ambulation status) 
Subjects who were categorized as “withdrawn” were not allowed to be used in the study 
as past medical records could not be accessed to extract certain information to complete the 
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Salzberg Scale assessment. Inaccessibility to data extraction was due to restrictions of the IRB. 
The items that needed to be extracted were albumin levels and hematocrit levels for each 
assessment date in order to have all variables of the Salzberg Scale accounted for in a score 
compilation. Subjects needed to have either albumin or total protein levels listed for the exact 
assessment date. Hematocrit levels also needed to be listed for the exact assessment date to 
maintain consistency and accurate data extraction. These values were not recorded for in the 
original database of the study. Access to this information could only be obtained through already 
consented patients or those who had passed away or had been lost to follow-up based on IRB 
specifications.  
4.3 DATA COLLECTION 
Data extraction from the original RERC-SCI study was a crucial component to the success of the 
compilation of Salzberg Scale scores. Two databases were used for the extraction of the data. 
The first was the original database used to hold the primary RERC-SCI study. This held the 
majority of the sought after variables. Categorical titles of information held in this database can 
be referred to in Table 3. The second database of information was the computerized medical 
records pertaining to each subject. Albumin and/or total protein levels and hematocrit levels for 
each included subject were found in these records. A secondary analysis spreadsheet was used to 
organize and input data specific to the current study for statistical analysis. This spreadsheet held 
categories for each risk factor of the Salzberg Scale, assessment dates and phase specifications 
(acute hospitalization or inpatient rehabilitation), ASIA scores, and demographic information. 
Exact categorical topics in the secondary analysis spreadsheet can be referred to in Table 4.  
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To begin data extraction for the secondary analysis database, operational definitions of 
the Salzberg Scale factors were first studied in detail in order to look for exact variables in the 
original database and computerized medical records of subjects. Operational definitions ranged 
from International Classification of Disease (ICD) definitions, quantitative measurements, to 
objective observational details. The objective observational details pertained to three of the 
fifteen risk factors. The three factors were level of activity, mobility, and urine incontinence or 
constantly moist. These factors were coded based on the expert opinion of the two nurses who 
assessed each subject in acute hospital and inpatient rehabilitation settings. Each of the nurses 
reviewed extensive medical record notation and assessment notes of each subject pertaining to 
the three risk factors. In order to eliminate bias or skewed coding of the three risk factors, the 
nurses of the primary study were given practice evaluations or scorings to compare the 
assessments. Out of 48 variables from 12 subjects, the nurses overlapped with identical scoring 
45 times (94%) showing strong consistency and similar coding methodology.  
 Within this population, the limiting factor or variable to determine if the subject would 
be included was albumin or total protein measurement availability. This was the first risk factor 
that was assessed to minimize obsolete data collection. For each qualified subject, albumin levels 
were taken from the medical records. This narrowed our search to 51 subjects that allowed 
calculation of complete Salzberg Scale scores.  
Based on the operational definition as well as measured value, a coded value was 
assigned based on the Salzberg Scale. This process was repeated for all fifteen risk factors for 
each assessment date. The only varying step was from where the data were taken in the second 








Figure 1 Data Collection Process 
Whether data were extracted from the RERC-SCI primary database of computerized medical 
records, variables were based on exact Salzberg operational definitions. Once each variable had 
been collected, all variables are summed together for a compiled Salzberg Scale Score. This was 
the number that was used in statistical analysis.    
Although each subject had complete Salzberg Scale scores for individual assessment 
dates, many subjects had missing data for Salzberg Scale score calculations over a large range of 
visits. A forward-carrying imputation method was initially attempted to account for each 
subject’s missing scores.  Based on large scale missing data of multiple subjects, an imputation 
method could not be used, as there would be too great of an assumption factor made when 
analyzing the dataset. Alternatively, a methodology evaluating the short term and long term use 
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 The available data was analyzed two ways to assess the predictive validity of the scale for 
this study population (see Figure 2 ). The first analysis looked at the short-term risk assessment. 
This grouping of the data, also known as next visit prediction group, would only include subjects 
who had a Salzberg Scale score followed by a study follow up for assessment of pressure ulcer 
development. When the subjects were scored in acute hospitalization, then the subject’s pressure 
ulcer assessment would range two to three days after the initial Salzberg Scale score compilation, 
as subjects were assessed three times a week as part of the primary study protocol. If the subject 
were scored in inpatient rehabilitation, then the subject’s pressure ulcer assessment would be five 
to seven days after the initial Salzberg Score compilation as subjects were assessed one time per 
week.  
This subject group captures the predictive validity of the Salzberg Scale when 
administered in a short-term, frequent method. Isolation of a direct time point for pressure ulcer 
formation could be highly correlated to a specific range of Salzberg Scores, as the obtained score 
of the initial visit would likely estimate the development of the PrU upon the following visit. 
Although only 28 subjects were included in this group, 55 pairings were gathered from these 
subjects. Two subjects were included in both the acute and inpatient settings whereas the other 
subjects were in either acute hospitalization on inpatient rehabilitation settings. Individual 
subjects contributed a range of one to six observation pairings to the 55 pairings used in 
statistical analysis as long as the assessment pairings fit the next visit prediction group criteria. 
















Table 5 Number of Observation Pairing Contributed Per Subject in Next Visit Prediction Group 
Number of Observations 
Pairings Contributed 
Number of Subjects in 
Acute 
Number of Subjects in 
Inpatient 
1 13 6 
2 0 2 
3 3 3 
4 2 0 
5 0 0 
6 0 1 
 
The second analysis, known as the multiple visits prediction group, gauged the predictive 
validity of the scale over a longer period of time in each setting. There is not a consistent number 
on how many times a risk assessment tool should be administered. Results of the Salzberg 
Scale’s predictive validity over long-term use with less frequent scorings would show whether 
frequent or less frequent administration of the scale should be implicated in a clinical setting. 
After the first assessment and compilation of the Salzberg Scale score for each time point of the 
subject in the multiple visits prediction group, PrU development was checked on the third 
assessment after the first observation. Assessment groupings were chosen if there was a 
beginning score and a following score assessed on the third assessment after the observation. If 
an assessment were missed between the first and third assessment, the grouping was still 
inclusive as the first and third assessment were complete.  
Three assessment dates between visits was determined as the greatest distance eligible for 
predictive value before other confounding variables may interfere with the relationship between 
the predictive qualities of the scale and PrU development. For subject in acute hospitalization, 
the time ranging in between three assessment dates was five to seven days since the initial 
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assessment. For subjects in inpatient hospitalization, the time ranging in between the three 
assessment dates was 18 to 22 days since the initial assessment. Although only 34 subjects were 
included in this group 77 pairings were gathered from all of the subjects. Three subjects were n 
both the acute and inpatient group. Subjects contributed a range of one to seven observation 
pairings for each patient that contributed to the total 77 pairings used in the statistical analysis. 
(See Table 6) As long as each subject’s assessment availability in the RERC-SCI data had the 
criteria of the assessment grouping, multiple time points could be included for analysis.  
Table 6 Number of Observation Pairing Contributed Per Subject in Multiple Visits Prediction Group 
Number of Observations 
Pairings Contributed 
Number of Subjects in 
Acute 
Number of Subjects in 
Inpatient 
1 14   6    
2 3  3   
3 2   3   
4 3  1    
5 0 0 
6 0 0 
7 1   1    
 
In addition, each subject group was evaluated based on the stage of rehabilitation in 
which their assessment occurred. Three analyses were performed based upon the stage of care. 
The first section contained all of the observation pairings from acute care rehabilitation and 
inpatient rehabilitation, also known as the total group. The second and third analyses of 
evaluation solely examined acute care rehabilitation and inpatient rehabilitation, respectively. 
Through the combined phase, or total stage approach, general score trends were evaluated. The 
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individual stages of treatment were evaluated to show if the scale has a greater predictive validity 
in acute hospitalization over inpatient rehabilitation or vice versa.  
4.4 DATA ANALYSES 
Exploratory and explanatory approaches were used to assess the data in order to evaluate the 
psychometric properties of the Salzberg Scale. An exploratory approach assesses qualitative 
trends in Salzberg Scale scores of included subjects with or without pressure ulcer development 
through box plots. A more in depth analysis occurs in the explanatory approach, which utilizes 
objective outcomes. In order to validate a scale, the scale’s results were tested for certain 
psychometric properties: sensitivity, specificity, negative predictive value (NPV), and positive 
predictive value (PPV). These calculations are further analyzed to assess the power of the 
prediction tool through the use of the Receiver Operating Characteristic (ROC) Curve.  
4.4.1 Box Plots 
Box plots are important for initial data analysis. When comparing data from two or more groups, 
they allow interpreters to see distributions of data and a summary of data. Box plot figures have 
similar characteristics. Whiskers on either end of x-axis categories represent the range or 
categorical spread of Salzberg Scores. The shaded rectangle between the whiskers represents the 
scores between the first and third quartile of scores. The diamond within the shaded rectangular 
space represents the average score and the horizontal line represents the median score of the 
population. Box plots assessed differences between the total group, acute care hospitalization 
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Figure 3 Generic Box Plot Characteristics 
4.4.2 Sensitivity and Specificity 
Sensitivity is defined as “the probability that a test will be positive for persons who actually 
have” pressure ulcer development.43 This is the fraction of subjects who have developed new 
pressure ulcers and are above a certain score on the Salzberg Scale predicted for risk. On the 
other hand, specificity is “the probability that a test will be negative for subjects who do not 
have” pressure ulcer development.43 Ideally, risk assessment tools should have a 100% 
sensitivity and 100% specificity rate. In real-world clinical use, this level of precision is not 
achievable. The accepted or reasonable predictive validity sensitivity and specificity rates are 
75% or higher.17, 43 Determining calculation of the sensitivity and specificity takes place initially 














Above Cut-off Score (At risk) a b 
Below Cut-off Score (Not at risk) c d 
 
In order to interpret Table 7, it is important to understand what each of the variables 
means. Data can be grouped under four different actualities, or outcomes. These are known as 
true positive, true negative, false positive and false negative results. True positive is the 
proportion of people who developed a pressure ulcer and were classified as at risk by the 
Salzberg Scale; true negative is the proportion of people who did not develop a pressure ulcer 
and were classified as not at risk by the Salzberg Scale. A false positive is the proportion of 
people who did not develop a pressure ulcer and were classified as at risk by the Salzberg Scale; 
a false negative is the proportion of people who develop a pressure ulcer and were classified as 
not at risk by the Salzberg Scale. Possible results of the data can be figuratively seen on Table 8. 
  
Table 8 Clinical Results Organizer for Sensitivity and Specificity 
 Actual  Clinical Result 
Salzberg Scale 
Classification 
 Develops Pressure 
Ulcer 
Does Not Develop 
Pressure Ulcer 
At risk True Positive (TP) False Positive (FP) 
Not at risk True Negative (TN) False Negative (FN) 
 
 
Sensitivity and specificity are presented as in the form of percentages. Each can be calculated by 
using the values from Table 7 and entering them into Equation 1 and Equation 2. Sensitivity and 
Specificity were taken for each Salzberg Scale score collected in both the next visit prediction 
group and the multiple visits prediction group.  
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Equation 1 Sensitivity Calculation 





Equation 2 Specificity Calculation 





4.4.3 Predictive Values 
In addition to sensitivity and specificity tests, Positive Predictive Values (PPV) and Negative 
Predictive Values (NPV) are also reported to determine the predictive validity of measurement 
tools.  Accuracy of PPV and NPV are useful when interpreting predictive value of individual 
assessments because the PPV and NPV account for incidence of new pressure ulcer development 
as well as the number of cases screened in the data set.18 The definition of PPV for this study is 
the probability that a subject who scored above the determined cut-off score will actually 
develop a pressure ulcer; the NPV for this study is the probability that a subject who scored 
below the determined cut-off score will not develop new a pressure ulcer. Calculation of PPV 
and NPV also utilize the variables seen in Table 7 in Equation 3 and Equation 4. Both PPV and 
NPV were calculated for each Salzberg Scale score collected for the next visit prediction group 
and the multiple visits prediction group.  
 
Equation 3 Positive Predictive Value 







Equation 4 Negative Predictive Value     





For a summary of accuracy terms, see Table 9.  
Table 9 Summary of Predictive Validity Terminology 
Term Definition 
Sensitivity The probably that a test will be positive for persons who actually have pressure ulcer development 
Specificity The probability that a test will be negative for subjects who do not have pressure ulcer development 
Positive Predictive 
Value (PPV) 
The probability that a subject who scored above the determined cut-off 
score will actually develop a pressure ulcer 
Negative Predictive 
Value (NPV) 
The probability that a subject who scored below the determined cut-off 
score will not develop new a pressure ulcer 
True Positive (TP) The proportion of people who developed a pressure ulcer and were classified as at risk by the Salzberg Scale 
True Negative (TN) The proportion of people who did not develop a pressure ulcer and were classified as not at risk by the Salzberg Scale 
False Positive (FP) The proportion of people who did not develop a pressure ulcer and were classified as not at risk by the Salzberg Scale 
False Negative (FN) The proportion of people who develop a pressure ulcer and were classified as not at risk by the Salzberg Scale 
 
4.4.4 ROC Curve 
A ROC Curve is the ideal choice of analysis when the variable of interest is continuous. An ROC 
curve allows a researcher to test threshold of the sensitivity or TP rate versus the specificity 
change over the Salzberg Scale. If the test threshold is high, there will be few FP. Graphically, 
the closer the ROC curve is to the diagonal, the lower the threshold and less useful the test is at 
discriminating between the TP and FP populations.39 The steeper the ROC curve, the better the 
test. To characterize the distance of the ROC curve to the diagonal on the graph, area under the 
ROC curve (AUC) measures the strength of the research tool quantitatively. Essentially, the 
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AUC is a measure of probability of how likely the test will reveal a TP. The closer the AUC is to 
0.5, the worse the test’s performance. The closer the AUC is to 1.0, the stronger the 
predictability of the test.74 An ROC curve can be constructed to measure the strength of the 




5.0  RESULTS 
The results section is presented as three distinct portions. The beginning portion states the 
demographics for each subject sample population, next visit prediction and multiple visit 
prediction. The second part of the results shows the exploratory analysis for both the next visit 
prediction group as well as the multiple visit prediction group. The third portion of the results 
section contains two subcategories specific to the sample population being discussed. The first 
explanatory results will discuss the next visit predictions group. The second explanatory 













 Table 10 Demographics of Next Visit Prediction Populations 
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Table 11 Demographics of Multiple Visits Prediction Populations 
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Table 12 Observation Pairings of the Next Visit Prediction Group 






Number of Observation 
pairings with PrU 
Development 
5 (9.0%) 2 (6.8%) 3 (11.5%) 
Number of Observation 
Pairings without PrU 
Development 
50 (91.0%) 27 (93.2%) 23 (88.5%) 
 
Table 13 Observation Pairings of the Multiple Visits Prediction Group 






Number of Observation 
Pairings with PrU 
Development 
9 (11.7%) 3 (6.7%) 6 (18.8%) 
Number of Observation 
Pairings without PrU 
Development 
68 (88.3%) 42 (92.7%) 26 (81.2%) 
 
5.1 DESCIPTIVE STATISTICS 
In the exploratory analysis, general predictive performance of the Salzberg Scale was analyzed 
for each subject group, next visit and multiple visits prediction group. Salzberg Scale scores for 
each group were evaluated for the three stages of care; combined acute hospitalization and 
inpatient rehabilitation (total group), acute hospitalization only, and inpatient rehabilitation only. 
The Salzberg Scale score of the first visit was used to create box plots for each of the three stages 
for each group.  
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5.1.1 Exploratory Analysis of Next Visit Predictions Groups 
The first three box plots represent the exploratory analysis of the next visit prediction group. 
Shown in Figure 4, subjects in the total group which did not include the development of a PrU 
(0) versus those that did include development of a PrU (1) had slightly different scores. 
Combined, the sample population of the next visit prediction group totaled 28 subjects sharing 
55 usable observation pairings for analysis. Comparisons of the mean Salzberg Scale score, 
maximum Salzberg Scale score, minimum Salzberg Scale score, and median Salzberg Scale 
score are shown in the Table 14 below. Five out of 55 observation pairings involved the 
















0: Lack of PrU Development 
1: PrU Development 
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Table 14 Total Population Box Plot Results of Next Visit Prediction Group 
 
 No PrU Development (0) PrU Development (1) 
Mean Salzberg Scale score 11.68 12.8 
Maximum Salzberg Scale score 20 19 
Minimum Salzberg Scale score 6 9 
Median Salzberg Scale score 11 10 
 
The second state, or acute care hospitalization, is shown in Figure 5. Comparisons of the mean of 
Salzberg Scale score, maximum Salzberg Scale score, minimum Salzberg Scale score, and 
median Salzberg Scale score are noted in Table 15. Out of the 28 subjects, 18 observation 
pairings had assessments scores available to analyze. Three observation pairings out of the 29 
developed PrU. Lack of PrU Development is denoted by 0 on the boxplot while development of 
PrU is denoted as 1.  
 
Figure 5 Acute Care Hospitalization Exploratory Comparison in Next Visit Prediction Group 
Key 
0: Lack of PrU Development 
1: PrU Development 
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Table 15 Acute Care Hospitalization Group Box Plot Results for Next Visit Prediction Group 
 No PrU Development (0) PrU Development (1) 
Mean Salzberg Scale score 13.0 17.5 
Maximum Salzberg Scale score 20 19 
Minimum Salzberg Scale score 8 16 
Median Salzberg Scale score 13 17.5 
 
The final state, or inpatient rehabilitation, is shown in Figure 6. Comparisons of the mean 
of Salzberg Scale score, maximum Salzberg Scale score, minimum Salzberg Scale score, and 
median Salzberg Scale score are noted in Table 16. Out of the fifty-five observation pairings, 23 
observation pairings’ scores were available to analyze. Three observation pairings out of the 23 
observation pairings involved the development of a PrU. Lack of PrU development is denoted by 








Figure 6 Inpatient Rehabilitation Exploratory Comparison for Next Visit Prediction Group 
 
Table 16 Inpatient Hospitalization Box Plot Results for Next Visit Prediction Group 
 
 No PrU Development (0) PrU Development (1) 
Mean Salzberg Scale score 10.0 9.7 
Maximum Salzberg Scale score 15 10 
Minimum Salzberg Scale score 6 9 
Median Salzberg Scale score 10 10 
 
5.1.2 Exploratory Analysis of the Multiple Visits Prediction Groups 
The second set of box plots represents the exploratory analysis of the multiple visits prediction 
group. The multiple visits prediction group analyzed a population of 34 subjects with a total of 
77 observation pairings. The first state was the total population, regardless of what stage of 
Key 
0: Lack of PrU Development 
1: PrU Development 
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hospitalization they were assessed. Shown in Figure 7, subjects in the total group who did not 
develop PrU (0) versus those who did develop PrU (1) had slightly different ranges in score.  
 
 
 Figure 7 Total Population Exploratory Comparison for Multiple Visits Prediction Group 
 
Comparisons of the mean Salzberg Scale score, maximum Salzberg Scale score, 
minimum Salzberg Scale score, and median Salzberg Scale score are shown in the Table 17 
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Table 17 Total Population Box Plot Results for Multiple Visits Prediction Group 
 
 No PrU Development (0) PrU Development (1) 
Mean Salzberg Scale score 12.4 13 
Maximum Salzberg Scale score 20 19 
Minimum Salzberg Scale score 6 9 
Median Salzberg Scale score 12 13 
 
The second state, or acute care hospitalization, is shown in Figure 8. Comparisons of the 
mean of Salzberg Scale score, maximum Salzberg Scale score, minimum Salzberg Scale score, 
and median Salzberg Scale score are noted in Table 18. Out of the 77 observation pairings, 45 
had assessments scores available to analyze. Three observation pairings out of the 45 involved 
the development of a PrU. Lack of PrU development is denoted by 0 on the boxplot while 
development of PrU is denoted as 1.  
 
Figure 8 Acute Care Hospitalization Exploratory Comparison for Multiple Visits Prediction Group 
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Table 18 Acute Care Hospitalization Box Plot Results for Multiple Visits Prediction Group 
 No PrU Development (0) PrU Development (1) 
Mean Salzberg Scale score 13.4 14.7 
Maximum Salzberg Scale score 20 19 
Minimum Salzberg Scale score 8 9 
Median Salzberg Scale score 13 14.5 
 
The final state, or inpatient rehabilitation, is shown in Figure 9. Comparisons of the mean 
Salzberg Scale score, maximum Salzberg Scale score, minimum Salzberg Scale score, and 
median Salzberg Scale score are noted in Table 19. Out of the 77 observations, 32 observation 
pairings were available to analyze. Six observation pairings out of the 32 involved the 
development of a PrU. Lack of PrU development is denoted by 0 on the boxplot while 
development of PrU is denoted as 1.  
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Table 19 Inpatient Rehabilitation Box Plot Results for Multiple Visits Prediction Group 
 No PrU Development (0) PrU Development (1) 
Mean Salzberg Scale score 10.9 9.7 
Maximum Salzberg Scale score 18 10 
Minimum Salzberg Scale score 6 9 
Median Salzberg Scale score 10 10 
 
 
5.2 PSYCHOMETRIC PROPERTIES EVALUATION 
5.2.1 Next Visit Prediction Group 
5.2.1.1 Total Population 
The explanatory data for this section are explained through four statistical analyses. The first 
statistical analysis shown in Table 20 is the basic calculation of sensitivity, specificity, and 
predictive values for the sample population data according to the Salzberg score received in the 
Total Group. The row highlighted in yellow represents that score with the balance of best 















PPV (%) NPV (%) 
6 100 4 9.4 100 
7 100 6 9.6 100 
8 100 20 11.1 100 
9 80 32 10.5 94.1 
10 40 46 6.9 88.5 
11 40 56 8.3 90.3 
12 40 60 9.1 90.9 
13 40 72 12.5 92.3 
14 40 80 16.7 93.0 
15 40 86 22.2 93.5 
16 20 88 14.3 91.7 
17 20 90 16.7 91.8 
18 20 96 33.3 92.3 
19 0 96 0 90.6 
20 0 100 0 90.1 
 
 
Sensitivity versus specificity is plotted against one another for each of the specific cutoff 
scores in Figure 10. The red line is representative of specificity while the blue line is 
representative of sensitivity. We see here that the intersection, or best balance between 
sensitivity and specificity for the total population, is located at a cut-off score of ten points. 
Noticeably seen in Table 20, PPV (%) values are extremely low in comparison to the higher 
NPV (%) values by an average difference of 53%.  
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Figure 10 Cut off Plot for Total Population 
 
Figure 11 represents the ROC curve for the total group based on the proposed cutoff 
score of ten from Figure 10. The AUC was calculated as for 0.5740. This analysis implies that 
the Salzberg Scale is a weak predictor of pressure ulcer development using ten as the 
discriminating cutoff score in acute rehabilitation. The closer the AUC is to 0.5, the more likely 
results are to result chance. The closer the AUC is to 1, the more likely the results are related to a 






















Figure 11 ROC of Salzberg Scale for Total 
 
5.2.1.2 Acute Hospitalization Only 
 
The second statistical analysis set shown in Table 21 explains is the basic calculation of 
sensitivity, specificity, and predictive values for the sample population data according to the 
Salzberg score received for the observations in acute care hospitalization only. The table shows a 
consistently high sensitivity for more scores beneath fifteen and high specificity scores above 
fifteen points. There is also a trend of extremely low NPV values of 3.1 or smaller. The row 













PPV (%) NPV (%) 
8 100 3.6 6.9 1.0 
9 100 21.4 8.3 1.3 
10 100 32.1 9.5 1.47 
11 100 42.9 11.1 1.75 
12 100 46.4 11.8 1.9 
13 100 60.7 15.4 2.5 
14 100 67.9 18.1 3.1 
15 100 75 22.2 4 
16 50 78.6 14.3 2.3 
17 50 82.1 16.7 2.8 
18 50 92.9 33.3 7.0 
19 0.0 92.9 0.0 0.0 
20 0.0 100 0.0 0.0 
 
 
Figure 12 shows that the ideal cutoff point between high risk and very high risk 
categories is at a Salzberg Scale score of 15. The originally proposed cutoff score between high 
and very high risk proposed through the original Salzberg study was 9. This is a six point 
increase from the originally proposed cutoff score which discriminated between high and very 
high risk groups.  
Figure 13 represents the ROC curve for the total group based on the proposed cutoff 
score of 15 from Figure 12. The AUC was calculated for 0.8482. This analysis implies that the 
Salzberg Scale is a strong predictor of PrU development using 15 as the discriminating cutoff 
score between high and very high risk groups in acute hospitalization. The closer to 0.5, the more 
likely results are likely to be of chance. The closer the AUC is to 1, the more likely the results 






























5.2.1.3 Inpatient Rehabilitation Only 
 
Lastly, the third statistical analysis set shown in Table 22 explains the basic outcomes of 
sensitivity, specificity, and predictive values for the sample population data according to the 
Salzberg score received in the inpatient rehabilitation group only. The row highlighted in yellow 
represents that score with the balance of best sensitivity to specificity. Based on the best balance 
between a sensitivity of 66.7% and a specificity of 45.5%, a score of nine is considered the ideal 
cutoff score within the inpatient observations. The balance is evident in the intersection in Figure 
17 at a score just above nine.  
.  







PPV (%) NPV (%) 
6 100 9.1 13.0 0 
7 100 13.6 13.6 0 
8 100 40.9 18.8 0 
9 66.7 45.5 14.3 0.7 
10 0 63.6 0 1.6 
11 0 72.7 0 1.4 
12 0 77.3 0 1.3 
13 0 86.3 0 1.2 
14 0 95.5 0 1.0 









Figure 14 Cut off Plot for Inpatient Rehabilitation 
 
Based on the extremely low to nonexistent sensitivity within these scores, the ROC curve 
showed an AUC of 0.4924 indicating the Salzberg Scale to be completely left to chance as a 














 Figure 15 ROC of Salzberg Scale for Inpatient Rehabilitation 
5.2.2 Multiple Visits Prediction Group 
5.2.2.1 Total Population 
As for the Multiple Visits Prediction Group, the same statistical analysis measures were 
considered. The total group set of analyses were attempted first. Table 23 shows their results in 
regards to sensitivity, specificity, PPV, and NPV values for each of the scores represented in the 
population. The row highlighted in yellow represents that score with the balance of best 














PPV (%) NPV (%) 
6 100 2.9 12 100 
7 100 4.4 12.2 100 
8 100 14.7 13.4 100 
9 77.8 26.5 12.3 90 
10 55.6 38.2 10.6 86.7 
11 55.6 47.1 12.2 88.9 
12 55.6 51.5 13.1 90.0 
13 33.3 61.8 10.3 87.5 
14 33.3 70.6 13.0 88.9 
15 33.3 80.9 18.8 90.2 
16 22.2 85.3 16.7 89.2 
17 22.2 86.8 18.2 89.3 
18 11.1 97.1 33.3 89.2 
19 0 97.1 0 0 
20 0 100 0 0 
     
 
The best balance seen is between sensitivity and specificity of 55.6% and 47.1 % 
respectively at a score of 11 points. The intersection can be seen in Figure 16. Despite its best 
balance, it is a very weak predictor of PrU development based on the ROC Curve in Figure 17.  
An AUC of 0.5458 does no correlate with strong predictive validity. The overall score of eleven 
is two points higher than Salzberg’s original nine point cut off between the high and very high 
risk group.  
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 Figure 16 Sensitivity vs. Specificity of Total Group 
 






5.2.2.2 Acute Hospitalization Only 
Next, the overall statistical calculation set was taken for acute care hosiptalization for the 
multiple visits prediction method. Shown in Table 24 are the results of sensitivity, specificity, 
PPV, and NPV for each Salzberg Scale score represented in the acute care hospitalization 
population. The row highlighted in yellow represents that score with the balance of best 
sensitivity to specificity. 







PPV (%) NPV (%) 
8 100 2.6 13.6 100 
9 83.3 17.9 13.5 87.5 
10 83.3 28.2 15.1 91.7 
11 83.3 35.9 16.7 93.3 
12 83.3 41.0 17.9 94.1 
13 50 51.3 13.6 86.9 
14 50 61.5 16.7 88.9 
15 50 71.8 21.4 90.3 
16 33.3 76.9 18.2 88.2 
17 33.3 79.5 20.0 88.6 
18 16.7 94.9 33.3 88.1 
19 0 94.9 0 86.0 
20 0 100 0 86.7 
 
Figure 18 shows that the ideal cutoff point between high risk and very high risk 
categories is at a rounded up Salzberg Scale score of 13. The originally proposed cutoff score 
between high and very high risk proposed through the original Salzberg study was nine. This is a 
noticeable four point increase from the originally proposed cutoff score. This particular group of 
data had the highest NPV scores showing its strong ability to decipher that the probability that a 
subject who scored below the determined cut-off score will not develop new a pressure ulcer. 
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The strength of identifying true negatives leads to a greater AUC of 0.5983 in the ROC Curve in 
Figure 19.  
 
Figure 18 Sensitivity vs. Specificity of Acute Care Hospitalization Group 
 







5.2.2.3 Inpatient Rehabilitation Only 
 
Lastly, the psychometric properties of predictive validity were calculated for the inpatient 
rehabilitation group. General means of calculation are seen in Table 25. The inpatient only group 
suffered from terribly low PPV and sensitivities at any score above 10 points. Its stronger factor 
was determining the NPV on almost all occasions. The row highlighted in yellow represents that 
score with the balance of best sensitivity to specificity. 
 







PPV (%) NPV (%) 
6 100 6.9 10 100 
7 100 10.3 10.3 100 
8 100 31.0 13.0 100 
9 66.7 37.9 10 91.7 
10 0 51.7 0 83.3 
11 0 62.1 0 85.7 
12 0 65.5 0 86.4 
13 0 75.9 0 88 
14 0 82.8 0 88.9 
15 0 93 0 90 
16 0 96.6 0 90.3 
17 0 96.6 0 90.3 
18 0 100 0 90.6 
 
The best balance between scores is seen at nine points with a sensitivity score of 66.7% 
and a specificity score of 37.9%. In Figure 20, after intersection of the sensitivity and specificity, 
there is a deep plateau of the sensitivity, which represents poor identification of a higher score 
than nine leading to identification of PrU development. Reflected in Figure 21, the AUC 
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represents the predictability of PrU development for inpatient rehabilitation group. The AUC 
was calculated for 0.5862. This was slightly less than the acute rehabilitation group calculation. 
This analysis implies that the Salzberg Scale is an inaccurate predictor of pressure ulcer 
development using nine as the discriminating cutoff score between high and very high risk 
groups in inpatient rehabilitation. 
 

















6.0  DISCUSSION 
The purpose of this study was to see evaluate the predictive validity the Salzberg Scale during 
acute care and inpatient rehabilitation following spinal cord injury by assessing of the scale’s 
psychometric properties. The SCI QUERI Expert Panel on Pressure Ulcer Research 
Implementation suggested there is a need to develop weighted models of risk factors as clinical 
resources for critically ill or high risk populations.36 The Salzberg scale weighs known PrU risk 
factors, but has not been evaluated for validity and/or reliability-since the reporting on its pilot 
study..36, 51 The three aims of the study were composed to create risk cut-off scores for new, 
traumatic SCI using the Salzberg Scale in order to incorporate the psychometric testing needed to 
evaluate predictive validity.  
The first aim was to verify the general statement that the Salzberg Scale has predictive 
risk capabilities. Based on the initial exploratory analysis, slightly higher average scores were 
seen for those who developed pressure ulcers alluding to possible predictive validity. When 
separating the population in to the next visits prediction and multiple visits prediction category, 
evidence of predictive validity no longer remained on the basis of average Salzberg Scale score 
being lower or similar to those who did not develop a PrU. With the purpose of seeing the scale’s 
predictive properties in acute hospitalization and inpatient rehabilitation, the scale was tested for 
varying psychometric properties of time to PrU assessment 2-3 days after all the way through 22 
days after assessment and stage of care including acute care hospitalization and inpatient 
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rehabilitation. Based on the exploratory analysis, the average score for a subject with pressure 
ulcer development was higher than those subjects that did not develop a pressure ulcer in the 
total and acute only settings. The biggest difference in average higher score was seen mainly in 
the acute hospitalization only. In contrast, there was lack of predictability based on the lower 
average Salzberg score in the inpatient rehabilitation. In regards to the first aim, this gave a weak 
initial impression that the scale had potential predictive ability as Salzberg believed that the 
higher the score of an assessment, the more likely the patient would be to develop a pressure 
ulcer.67 
The second aim of the study was to identify an optimal risk cut-off score for developing a 
pressure ulcer in this extremely high-risk study population. This aim was completed by 
determining the best sensitivity versus specificity to find an optimal balance in scores based on 
the group and stage of care. This ultimately allowed for an opportunity to discuss risk categories 
for those in acute hospitalization and inpatient rehabilitation versus SCI individuals in a general 
sense as the pilot Salzberg Scale study addressed. In each group and sub-setting, an overall 
average cut-off score among the acute, traumatic injury group in similar methods to Salzberg’s 
original study was identified. This aim identified PrU or lack of PrU development through risk 
score using a dichotomous method rather than four risk categories. Regardless of the score, 
Salzberg noted that there would always be “risk” for development of PrU as related to the four 
categories with the “low risk” being the minimal score. Rather than defining four categories of 
risk, the second aim was used to set a general standard score associated with risk in the new, 
traumatic SCI population.   
The third and final aim was to use the newly calculated cut-off scores to evaluate the 
accuracy of the Salzberg scale for predictive capabilities and risk evaluation using ROC curve 
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analysis. When the psychometric properties were analyzed using the ROC curve, the results of 
the study suggested that the Salzberg Scale in actuality is a weak predictive assessment tool for 
PrU development based on the balanced cut-off scores. The results which ignore stage of care, or 
the total group, in both the next visit prediction group and multiple visit prediction group 
exhibited nearly identical outcomes of 0.5740 and 0.5458 respectively. AUC is indicative of a 
poor diagnostic test when the results are 0.50-.60.74 This means that the Salzberg Scale score 
cannot distinguish risk over administration periods greater than 5-7 days for PrU development in 
this sample group. These results were also seen in the inpatient rehabilitation for next visit 
predictions group as well as the acute care and inpatient rehabilitation of the multiple visits 
prediction group. To reiterate, an AUC of 0.5 means that the likelihood of the assessment tool 
predicting PrU formation correctly is left to chance or toss-up. Elevated AUC represents 
discrimination of the assessment tool and its decimal is the percentage of randomly drawn pairs 
which are true.  
One stage of care, the acute care hospitalization of the next visits prediction group 
showed good predictive validity with an AUC of 0.8482. Due to 100% sensitivity for subjects 
scoring 8-15 points, suggestion that all of these scores were correctly identified relates to the 
passing AUC in the ROC curve. The greatest balance of sensitivity and specificity for this phase 
of care, as seen in Figure 15, is at 15 points where the sensitivity was 100% and the specificity 
was 75%. Unlike the acute phase of the multiple visits prediction group, which had an AUC of 
0.5983, we can see that reviewing results immediately after assessment, 2-3 days, is the more 
accurate way to predict PrU development in acute care hospitalization, possibly due to rapid 
changes in health level. A few weeks between assessments may weaken the association of 
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Salzberg Scale factors and their impact on risk as compared to other confounding variables such 
as implicated prevention techniques in the hospital and health improvement over time.  
The multiple visits prediction group had a significant decrease of balance of sensitivity to 
specificity of 50% to 51.3%, which may be associated with a higher identification of true 
negatives as compared with the next visits predictions group in acute care hospitalization. The 
Salzberg Scale should have a high sensitivity so it is able to correctly identify as many 
individuals as possible positively (true positive). This also is the same standard needed to 
identify as many negative individuals when dealing with the concept of specificity. Being that it 
is highly difficult to achieve near perfection in sensitivity and specificity, a cut off level is based 
on a higher sensitivity, in the case of next visit prediction versus multiple visit predictions, as it 
is imperative not to miss the presence or risk of pressure ulcer development.39 In Salzberg’s 
original results, the balance of sensitivity and specificity had a higher specificity score in initial 
hospitalization of 84.2% as compared to sensitivity of 36.8% which is not favored.51, 65, 68 
Tailoring the Salzberg Scale to deliver a higher sensitivity is one aspect of the scale’s properties 
that should be improved with refinement of risk evaluation in the new, traumatic SCI population.  
Moving forward, it is noticeable that there are low PPV throughout next visit prediction 
group and multiple visit prediction group analyses. This can be attributed to the low incidence of 
pressure ulcer development in each category. The PPV will never be close to 100% even if the 
sensitivity and specificity are high such as in the next visit predictions group of acute care 
hospitalization.39 When screening a population with very low incidence, it is inevitable that 
many people with positive test results will in fact be false positives or a Type II error.5 In 
addition, low PPV may be associated with the effect of preventative measures used while 
subjects are being treated in the settings. For instance, subjects were not limited to prevention 
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techniques such as support surface technology, skin assessment or tissue integrity assessment, or 
pressure-relief turning schedules. These techniques would reduce the likelihood of PrU 
formation in an already high-risk population. In addition, the level of a patient’s health improved 
during their stay in the hospital or inpatient facility, which led to decreased risk in development 
of pressure ulcers, thus decreasing the probability.39 If PrU incidence in this sample population 
had in fact been higher, it is likely that the PPV would have been higher and the NPV would 
have been lower.4 The incidence of PrU development in the RERC on SCI study was 42% as 
compared to an average of 32% incidence in the past year found by Saladin et. al and 43% 
incidence in the past year found by Krause et al.42, 63 Being that the incidence of the study 
population had an incidence of 9% to 11.7%, the lower incidence isn’t necessarily representative 
of the general population trends.  
Another variation between Salzberg’s preliminary results and this study’s are differences 
in the population demographics. The two populations cannot be directly compared as populations 
are so different. Thus, the approach of dichotomous risk versus four categorical risk levels 
cannot be precisely equated.  The difference in SCI patient may have impacted the cut-off scores 
greatly. Salzberg’s sample population consisted of 219 patients who had endured injury for 17.2 
± 12.1 years.67 On the other hand, the sample population of new, traumatic SCI patients had only 
endured injury for 35 ± 45 days. Drastic difference in human physiology impacts the secondary 
complications or risk factors that are accounted for in the scale. For instance, most patients in 
acute care hospitalization are bedridden due to intubation after initial traumatic spinal cord 
injury. This impacts the score by nearly seven points as their level of activity and mobility is 
nearly non-existent. As for the population of Salzberg, only two patients were confined to a bed 
and those temporarily hospitalized used mobility and activity data from a baseline state.65 In 
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addition, the entire sample population of this study was in a hospital setting. This added two 
additional points to the entire population’s total score, shifting the average score of the subjects 
to a higher cut-off. In Salzberg’s population, the patients varied greatly with only 3% living in a 
nursing home or hospital at the time of the assessment.  
After reviewing the various differences in populations, it can be seen that there are 
inconsistencies in the cut-off scores based on the elapsed time since injury of the patient. 
Salzberg’s pilot study did not include a large group of newly, traumatic spinal cord injury 
patients which this study’s entire sample population included. Salzberg recommended cut-off 
scores for a population specifically focused on outpatient care of 6-8 points for high risk, when 
newly, traumatic spinal cord injury have an average high risk score of 11 (range of 9-15 points). 
It is necessary for the subpopulations to be evaluated within the SCI population and tested for 
different levels of risk with the Salzberg Scale. The overall greater score suggests that patients in 
acute care hospitalization are automatically more susceptible to the development of PrU based on 
a higher point accumulation and need different weights on risk factors to differentiate from who 
is at risk and who is at extremely high risk of development.  
Salzberg’s Scale weighted risk factors must be modified to better accommodate the 
drastic changes between those patients in acute care hospitalization after traumatic spinal cord 
injury versus those who have endured long-term injury. In addition, the Salzberg Scale is not fit 
to measure the risk of the new, traumatic SCI population based on the results of the ROC curve 
unless it was short term administration of the scale  (See Figure 14, Figure 18, Figure 20, Figure 
22, Figure 24.) Left to chance, this scale is seen as unfit for subjects with newly, traumatic spinal 
cord injury unless specifically used in acute-care hospitalization every 2 to 3 days for 
reassessment. Potentially reevaluating the inpatient population using a 2-3 day administration 
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plan as opposed to a 5-7 day plan may result in better predictability of the scale. To confirm 
these results, another study using a cut off score of 15 points and newly, traumatic SCI patients 
in acute care hospitalization should be performed in addition to short-term administration in the 




7.0  CONCLUSIONS, LIMITATIONS, FUTURE WORK 
The results of the study suggest that the Salzberg Scale is unfit for subjects with newly, traumatic 
spinal cord injury unless specifically used in acute-care hospitalization every 2 to 3 days during 
medical assessments. However, these results were obtained using a small sample size and 
subjects limited to certain criteria that may vary from the general SCI population. This study 
presented various limitations. If this study were to be repeated, I would suggest using a 
prospective method along with patients in various medical settings outside of a direct hospital 
facility. I believe using a prospective method would be easier to set consistent follow-up dates 
for patient assessments and have a more accurate account of level of mobility, activity, and 
incontinence. In this study, the use of opinion from patient nurses through medical record 
analysis could have altered the precise coded values despite using expertise of the nurse to 
declare these values. In addition, short-term administration of the Salzberg Scale in the inpatient 
rehabilitation should be implemented in order to see the scale’s applicability to other settings. 
Also, a prospective study would lend itself to a more accurate assessment of moisture control 
rather than relying on notes pertaining to catheterization changes and subjectivity of medical 
record interpretation.  
In addition, I believe that it is important for the study to have albumin scores collected for 
every single assessment to avoid the use scattered scores and more than one observation from 
subjects accounted for in statistical analysis. Though the next visit prediction and multiple visit 
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prediction group calculations accounted for repeated subjects, this method may have impacted 
the results by not comparing identical population groups and varied subject demographics. 
Regarding my suggestion about patients living in various residential settings, the entire 
population worked with was in a hospital at the time of assessment. This automatically inflated 
the total score by one point. Being in a hospital setting, we were more likely to see patients who 
were intubated or sedated and had no capability of activity, which is the most heavily weighed 
component in the scale as well. This outcome led to inflated scores and potentially a higher 
cutoff score as seen in the results. Lastly, we only worked with patients directly after the 
traumatic injury, which is different from someone who suffers from traumatic injury but does not 
have the immediate secondary medical complications that also inflate the total score. 
After recognizing these limitations, I believe that if corrected, the Salzberg Scale could 
show promising risk assessment of pressure ulcer development in the SCI population. With 
strong evidence of weak predictive validity based on ROC Curve results, I believe studies should 
use the higher cut off scores in both the acute and inpatient rehabilitation settings as well as the 
presented cut off score to see which scoring method and specify a scale for those of acute care 
hospitalization or new, traumatic injury versus outpatient care. Future studies should use the 
originally presented cutoff score from Salzberg’s study with a control group and the newly 
identified cut off scores with the experimental group. The same group of patients could be used 
in both test groups for exact consistency and comparison.    
Once the cut-off scores are solidified on the Salzberg Scale, I would like to see a head to 
head comparison of the Salzberg Scale predictive validity with the Braden Scale predictive 
validity in the same SCI population. WB Mortenson et al. recommended that the Braden Scale 
still be used based on the lack of psychometric testing of the Salzberg Scale. With the Salzberg 
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Scale pilot study and this study producing contradictory results and extreme cut off score 
difference, there is a need to see if changes made to the Salzberg scale hold up to the previous 
validation of the Braden Scale. This will provide the first study that presents which measurement 
tool is more accurate for risk identification using the same population. It will also answer many 
questions posed by those who speculate that a scale designed specifically for the SCI population 
will be a better indicator of risk than of a general assessment.  Lastly, univariate analysis of the 
fifteen individual risk factors of the Salzberg Scale should be evaluated in order to determine if 
certain risk factors contribute more to the prediction of PrU development over others. Potential 
redistribution of coded values and elimination of risk factors may be identified if analysis is 
completed.  
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